The choice of model organism is central to the study’s design. The team used Drosophila melanogaster flies genetically modified to express human amyloid-beta 42, the sticky peptide that aggregates into the plaques characteristic of Alzheimer’s disease. Although flies are distant from humans on the evolutionary tree, they share a remarkable proportion of their genes with people, and many of the molecular pathways implicated in neurodegeneration, including oxidative stress responses, cholinergic signalling, and tau phosphorylation cascades, are conserved. Fruit flies also live for only weeks, which means researchers can observe the full course of a neurodegenerative process and test interventions across the lifespan in a matter of days, something impossible in rodent or human studies. In this experiment, the Alzheimer-model flies were treated with the Caralluma extract for fourteen days before being assessed.

The behavioural results were the most visible evidence of benefit. Flies carrying the human amyloid-beta 42 gene typically show progressive deterioration in climbing ability, a standard measure of locomotor function in fly neurodegeneration research, as well as impaired grooming and deficits in learning assays. Treated flies performed significantly better across these measures and lived longer than their untreated counterparts. The researchers used an aversive phototaxis suppression assay to probe learning and memory, a test that measures a fly’s ability to suppress its natural attraction to light when that light is paired with an unpleasant stimulus. Improved performance in this assay suggests that the extract protected cognitive function, not merely motor capacity, although the authors are careful to frame these as preliminary findings in an invertebrate system.

Beneath the behavioural improvements, the biochemical data pointed to a familiar theme in neurodegeneration research: oxidative stress. The brains of Alzheimer-model flies suffer from an excess of reactive oxygen species that damage lipids, proteins, and DNA. The team measured malondialdehyde, a breakdown product of lipid peroxidation that serves as a marker of oxidative damage, and found it reduced in treated flies. At the same time, levels of the antioxidants glutathione and superoxide dismutase, two of the cell’s primary defences against oxidative injury, were increased. This shift in the balance between oxidative damage and antioxidant capacity is consistent with a neuroprotective effect and aligns with the known chemistry of many plant-derived polyphenols, which can act as antioxidants directly and can also induce the cell’s own antioxidant defence systems.

Perhaps the most pharmacologically interesting finding concerned acetylcholinesterase, the enzyme that breaks down the neurotransmitter acetylcholine. Cholinergic neurons in the brain are among the earliest casualties of Alzheimer’s disease, and the loss of acetylcholine contributes substantially to the memory impairment that defines the condition. Four of the currently approved Alzheimer’s drugs, including donepezil and galantamine, work by inhibiting acetylcholinesterase to keep acetylcholine available for longer in the synaptic cleft. In the treated flies, acetylcholinesterase levels were significantly reduced, suggesting that the extract may reproduce, at least partially, the mechanism of existing symptomatic therapies through a natural product mixture.

The molecular layer of the study focused on tau, the microtubule-associated protein whose pathological tangles inside neurons form the second hallmark lesion of Alzheimer’s disease alongside amyloid plaques. Quantitative analysis showed that the fly equivalent of the tau gene, dTau, was downregulated in extract-treated flies compared with untreated Alzheimer-model flies. Because tau pathology correlates more closely with cognitive decline than amyloid burden in human disease, any intervention that reduces tau expression or the signalling that drives tau phosphorylation attracts considerable attention. The researchers propose that the extract may be acting upstream of tau through pathways that connect amyloid toxicity to tau dysfunction.

To explore those upstream connections, the team turned to molecular docking, a computational technique that predicts how well small molecules fit into the binding pockets of target proteins. They focused on two enzymes with central roles in Alzheimer’s biology: glycogen synthase kinase-3, known as GSK3, and beta-secretase 1, known as BACE1. GSK3 is the major kinase that phosphorylates tau in the brain, promoting its aggregation into tangles, and it also participates in inflammatory and apoptotic signalling. BACE1 is the enzyme that performs the first cut in the production of amyloid-beta from its parent protein, making it a prime drug target for reducing amyloid generation. Docking simulations suggested that several phytochemicals present in the extract interact favourably with both enzymes, with catechin, a flavonoid found in many plants, showing the most promising predicted binding profiles against GSK3 and BACE1 alike.

The authors are explicit that docking is a hypothesis-generating tool rather than proof of mechanism. Predicted binding energies do not confirm that catechin or any other constituent of the extract actually inhibits GSK3 or BACE1 inside a living organism, and the extract is a complex mixture whose active components and their concentrations remain to be fully characterised. The study also did not directly measure amyloid-beta deposition or tau phosphorylation in the fly brains, so the link between the observed gene expression changes and the actual pathological lesions of Alzheimer’s disease remains to be established. Direct target validation, the authors note, together with assessment of amyloid and tau pathology and studies in mammalian models, will be required before any therapeutic relevance can be claimed.

Even with those caveats, the study fills a genuine gap. Caralluma dalzielii has a long history of traditional use for neurological complaints in the region where it grows across the Sahel and West Africa, yet it had never previously been evaluated in an experimental model of Alzheimer’s disease. Its close relative Caralluma fimbriata has been studied mainly for appetite suppression, and the genus as a whole remains underexplored relative to its chemical richness. Plants in this group produce an array of pregnane glycosides, flavonoids, and other secondary metabolites, and the new findings suggest that some of these compounds may act on multiple nodes of the Alzheimer’s disease network simultaneously, a polypharmacology that single-target drugs often lack.

The research also demonstrates the continuing value of the humble fruit fly in early-stage drug discovery. A complete behavioural, biochemical, and molecular evaluation of a natural product extract was accomplished in a model system that is inexpensive, rapid, and free of the ethical and logistical constraints of vertebrate studies, supported by funding from Nigeria’s TETFund institutional research programme. For a disease that affects tens of millions of people worldwide and for which approved therapies offer only modest symptomatic benefit, the pipeline of candidate compounds needs every accessible entry point. The Nigerian team’s results do not amount to a treatment, and no one should interpret them as a recommendation to seek out the plant itself. What they provide is a rigorous preliminary signal, generated through a transparent and reproducible workflow, that Caralluma dalzielii deserves a place in the queue of natural products being screened for Alzheimer’s drug discovery. If catechin and its neighbours in the extract can be isolated, validated against GSK3 and BACE1 in vitro, and tested in mammalian models of the disease, this Sahelian succulent may yet contribute more to modern medicine than its traditional reputation alone ever suggested.

Subject of Research: Neuroprotective effects of Caralluma dalzielii extract in a transgenic Drosophila model of Alzheimer's disease

Article Title: Targeting Alzheimer’s disease pathways with Caralluma dalzielii: behavioural, biochemical, and molecular evidence from a transgenic Drosophila melanogaster model

Article References: Ugwah-Oguejiofor, C. J., Hassan, E., Yakubu, D., Ahmed, A. H., Almustapha, Z., & Imam, M. U. (2026). Targeting Alzheimer’s disease pathways with Caralluma dalzielii: behavioural, biochemical, and molecular evidence from a transgenic Drosophila melanogaster model. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05637-3

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05637-3

Keywords: Caralluma dalzielii, Alzheimer's disease, Drosophila melanogaster, amyloid-beta 42, tau, GSK3, BACE1, acetylcholinesterase, oxidative stress, catechin, phytochemicals, molecular docking

Pancreatic lipase sits at the center of one of the most popular pharmacological strategies for weight management. The enzyme hydrolyzes triglycerides from food into absorbable fatty acids and monoacylglycerides, and blocking it reduces the fraction of dietary fat the body actually takes in. The only drug approved for this purpose, orlistat, works by forming a stable covalent bond with the catalytic residue serine 152 of the enzyme, permanently disabling it while its long hydrocarbon tail wedges into the enzyme’s hydrophobic groove, mimicking a triglyceride substrate. Although effective, orlistat is associated with gastrointestinal side effects, and pharmacovigilance analyses of adverse event databases have kept interest alive in gentler, plant-derived alternatives. That is where Garcinia species, famous for their polyphenols and xanthones, enter the picture, and where the lesser-known G. parvifolia, traditionally used in indigenous medicine across Southeast Asia, has remained almost entirely unstudied with respect to fat digestion.

The research team harvested fully ripe fruits in July 2024 from Penampang in Sabah, collecting samples from seven independent trees of comparable age to capture biological variability, with permits from the Sabah Biodiversity Centre and voucher specimens verified at the Borneensis Herbarium of Universiti Malaysia Sabah. The fruit peels were dried at 40 degrees Celsius, ground, sieved, and then extracted with four solvents of escalating polarity: 70 percent ethanol, acetone, chloroform, and hexane. The logic was straightforward. Because solvent polarity determines which classes of metabolites dissolve, comparing extracts across the polarity gradient would reveal whether the anti-lipase activity tracks with polar phenolics, lipophilic terpenes, or something in between. Ultrasonic-assisted extraction, which can reach efficiencies of 85 to 97 percent under mild conditions, was used to pull the chemistry out of the powdered peel.

The enzyme assays delivered a clear verdict. The 70 percent ethanol extract inhibited pancreatic lipase most strongly, with a half-maximal inhibitory concentration of 85.3 micrograms per milliliter, followed by acetone at 106.4 micrograms per milliliter, while the chloroform and hexane extracts performed far worse, never reaching fifty percent inhibition even at the highest tested concentration of 100 micrograms per milliliter. Orlistat, the positive control, inhibited the enzyme by 83 percent at just 25 micrograms per milliliter, with an IC50 of 17.5 micrograms per milliliter, validating the assay. The pattern pointed squarely at polar chemistry: whatever was blocking the enzyme dissolved best in aqueous ethanol, not in the greasy non-polar solvents. Inhibition rose steadily with concentration across all extracts, but the polar extracts dominated at every dose.

To see which molecules were responsible, the team turned to proton nuclear magnetic resonance spectroscopy, acquiring spectra on a 500 megahertz instrument and processing them with standardized binning across the chemical shift range of 0.5 to 10 parts per million. In total, thirty-four metabolites were annotated, drawing on the Chenomx database, the Human Metabolome Database, and two-dimensional J-resolved spectra to confirm assignments. The ethanol extract was by far the richest, showing intense signals from sugars such as glucose and xylose, amino acids, organic acids, and, critically, phenolic compounds. Distinctive peaks at 3.95, 4.60, and 6.99 parts per million were assigned to catechin, a flavonoid with a well-known track record against digestive enzymes, while signals in the downfield aromatic region hinted at phenolic acids such as protocatechuic and gallic acid, both common in Garcinia species. The chloroform and hexane spectra were comparatively barren, especially in the 2.5 to 5.5 parts per million region where hydrophilic metabolites cluster.

The statistical machinery of metabolomics then connected chemistry to biology. Principal component analysis separated the four extracts cleanly along the first principal component, which alone explained 89.1 percent of the variance and tracked the gradient from polar to non-polar constituents; together the first two components accounted for 97 percent of the total. Polar metabolites such as glucose, fructose, succinate, betaine, choline, and various amino acids loaded strongly on the positive side, where the ethanol and acetone extracts clustered, while the sterol beta-sitosterol and the sesquiterpene beta-caryophyllene associated with the non-polar side. A partial least squares regression then linked the spectral data directly to measured lipase inhibition, pairing each of the 28 spectral profiles with its own non-averaged inhibition value. The model performed impressively, with cumulative R-squared values of 0.97 for the X matrix and 0.967 for the Y variable, and a predictive Q-squared of 0.963. A 100-iteration permutation test confirmed the model was not overfitted, with all permuted values falling below the original and a negative Q-squared intercept of minus 0.266, a strong indicator of predictive validity.

The variable importance in projection analysis drove home the study’s central message: no single compound dominated. Catechin, catechol, mandelate, and indole-3-lactate scored high, but so did amino acids and derivatives such as aspartate, beta-alanine, and trans-4-hydroxy-L-proline, along with organic acids like succinate and isocitrate. In the PLS biplot, the ethanol and acetone extracts sat closest to the lipase inhibition vector, and the metabolites aligned with that vector formed a broad coalition of phenolics, aromatics, and primary metabolites rather than a lone star. The authors interpret this as evidence of additive or synergistic interaction: the primary metabolites are not direct inhibitors themselves, but their abundance signals a metabolically rich matrix that may amplify the effects of the true inhibitors, while betaine and choline, both linked to lipid metabolism regulation, may play supportive secondary roles.

Molecular docking with AutoDock Vina against the pancreatic lipase crystal structure provided a mechanistic coda. Catechin bound with an affinity of minus 6.09 kilocalories per mole, forming a network of hydrogen bonds with the catalytic triad residues serine 152 and histidine 263, effectively capping the active site and stabilizing a non-functional conformation of the enzyme. Beta-sitosterol, despite a slightly more favorable score of minus 6.34 kilocalories per mole, relies almost entirely on van der Waals forces, wedging into the greasy substrate channel and physically blocking triglyceride entry through steric hindrance. Beta-caryophyllene, at minus 5.19 kilocalories per mole, binds only hydrophobically and, being smaller, makes fewer contacts. The docking results align neatly with the wet-lab data: the lipophilic hexane extract, rich in sitosterol-type chemistry, performed poorly in the aqueous assay buffer, while the catechin-rich polar extracts excelled, suggesting that reversible hydrogen bonding to the catalytic machinery matters more in this system than non-specific hydrophobic plugging.

The authors are candid about the limits of the work. Bioactivity was assessed only in vitro and in silico, with no cellular or animal validation; docking was restricted to three representative metabolites rather than the full set of top-ranked variables; metabolite identification was qualitative rather than quantitative; and the samples were oven-dried rather than lyophilized. Docked complexes were not subjected to molecular dynamics simulations to test pose stability, and pure standards were not used to confirm the docking predictions. Even so, the study stands as a compelling demonstration that the anti-obesity potential of G. parvifolia is governed by a complex, multi-component synergy, and it positions this underutilized Bornean fruit as a candidate for functional foods and nutraceutical formulations. The researchers call for in vivo studies and clinical trials to establish safety, bioavailability, and real-world efficacy, but the broader lesson is already clear: when it comes to plant-based enzyme inhibition, the whole phytochemical orchestra, not just the first violin, may be what makes the music.

Subject of Research: NMR-based metabolomics of synergistic pancreatic lipase inhibition by Garcinia parvifolia metabolites

Article Title: Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR–based metabolomic deciphering of ligand interactions

Article References: Noordin, A. I., Abu Bakar, F. I., Saikim, F. H., Wichienchot, S., Isha, A., & Abu Bakar, M. F. (2026). Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR–based metabolomic deciphering of ligand interactions. Metabolomics, 22(5), Article 167. https://doi.org/10.1007/s11306-026-02536-z

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02536-z

Keywords: Garcinia parvifolia, pancreatic lipase, metabolomics, NMR spectroscopy, molecular docking, catechin, anti-obesity, natural products, phenolic compounds, functional foods, Malaysian Borneo, synergy

The research, led by Patricia Rodríguez-Castillo and colleagues at Tecnológico de Monterrey, tackles a fundamental problem in food chemistry. In cereal and pseudocereal grains, many phenolic compounds are not freely floating in the cell interior. Instead, they are esterified or otherwise bound to cell-wall polymers and other macromolecular structures. This bound fraction can represent a large share of the total phenolic pool, and unless the matrix is physically disrupted, standard solvent extraction simply cannot reach it. Hydroxycinnamic acid derivatives of genuine nutritional significance may remain locked inside structural fractions, leading analysts to underestimate the true antioxidant wealth of the seed.

DIC offers a strikingly elegant solution. The process works like a controlled steam explosion: amaranth grains are loaded into a reactor, a preliminary vacuum is drawn, and dry saturated steam is injected until a target pressure is reached. After a precisely timed hold, the pressure is dropped almost instantaneously toward a deep vacuum, at rates exceeding 0.5 megapascals per second. This sudden decompression forces the moisture inside the grain to flash-evaporate, cooling the material instantly while simultaneously causing it to expand and develop a sponge-like network of microstructural alveoli. The resulting porous architecture makes it far easier for solvents to penetrate the matrix and leach out compounds that were previously physically entrapped within the cell-wall network.

To test how these thermomechanical forces translate into chemical changes, the team worked with two Mexican subvarieties of A. hypochondriacus, Laura and Criollo, from the 2023 harvest in Puebla. They designed a rigorous central composite experiment spanning thirteen treatment combinations, with steam pressure ranging from 0.10 to 0.40 megapascals and processing times from 10 to 90 seconds. Treated and untreated grains were then ground, extracted with ethanol, and analyzed by high-performance liquid chromatography to quantify individual phenolic compounds, while the lipid fraction was characterized by gas chromatography-mass spectrometry.

The results for the Criollo variety were remarkable. Total quantified phenolics ranged from a low of 346.14 micrograms per gram under mild conditions to a striking 3035.2 micrograms per gram at moderate settings of 0.25 megapascals and 50 seconds, a condition that more than tripled the untreated control’s 828.38 micrograms per gram. Catechin emerged as the dominant compound in every sample, soaring from 679 micrograms per gram in the control to as much as 2704 micrograms per gram after treatment. Rutin, quercetin, gallic acid, and trans-4-hydroxycinnamic acid all showed statistically significant increases across most treatments, and the most favorable conditions also produced the widest diversity of detected compounds, with seven of eight identified peaks appearing in the chromatograms.

The Laura variety told a more nuanced story, one that underscores how sensitive these responses are to both genetics and processing intensity. Here, the same moderate condition of 0.25 megapascals for 50 seconds again delivered the highest phenolic concentration at 2074.15 micrograms per gram, though this did not differ significantly from the untreated grain. More revealing was what happened under harsher treatment: at 0.36 megapascals for 78 seconds, total phenolics collapsed to just 281.51 micrograms per gram and only three of ten peaks remained detectable. The contrast between this sample and DIC 6, which shared the same pressure but ran for only 22 seconds and displayed nine peaks, suggests that prolonged exposure to high-pressure steam can actively degrade delicate bioactive compounds rather than merely failing to release them.

Response surface modeling and Pareto analysis confirmed these patterns statistically, showing that moderate to high pressure combined with moderate time frames consistently maximized phenolic recovery, while quadratic terms in the fitted equations captured the penalty for pushing conditions too far. The findings align with earlier work by the same group showing improved antioxidant capacity in DIC-treated amaranth, as well as studies on green lentils, grape pomace, and oleaster flour, all of which reported enhanced polyphenol extractability following thermomechanical texturing. Together they paint a coherent picture: the sweet spot lies in enough mechanical disruption to fracture cell walls, but not so much thermal load that phenolics break down.

Crucially, the team also asked whether this violent process damages the lipid fraction, a legitimate concern given that unsaturated fatty acids and minor lipids like squalene are notoriously vulnerable to oxidation and heat. The answer was reassuring. Gas chromatography-mass spectrometry confirmed that amaranth oil remained dominated by nutritionally favorable components: in Criollo, oleic acid accounted for roughly 27 percent, linoleic acid 21 percent, palmitic acid 11 percent, and squalene an impressive 26 percent of the oil. Laura showed a similar pattern with 24 percent oleic, 25 percent linoleic, 20 percent palmitic, and 19 percent squalene. Saturated fatty acids made up only 22 to 30 percent of the total, preserving the grain’s balanced lipid signature.

Squalene deserves particular attention here. This triterpenoid, found in significant quantities in amaranth oil, exhibits documented antioxidant, anti-inflammatory, hepatoprotective, and cardioprotective activities, and it is one of the main reasons amaranth oil commands interest beyond basic nutrition. The study found that processing parameters did influence the relative proportions of specific fatty acids, with lower pressures and longer times favoring higher linoleic acid percentages in Criollo, and lower pressures boosting squalene in Laura, while oleic acid remained largely indifferent to the treatments. Some minor saturated fatty acids, including stearic and arachidic acid, disappeared from certain treatments, echoing similar observations in DIC-processed cardamom seeds and hinting at selective effects on less abundant lipid species.

The broader implications are compelling for the functional food industry. Amaranth’s phytochemical profile, spanning hydroxybenzoic acids, hydroxycinnamic acids, and flavonoids related to quercetin and kaempferol, varies considerably with species, genotype, and growing conditions, which has long complicated its use as a standardized ingredient. This study demonstrates that DIC is not merely a passive processing step but a tunable dial: by adjusting steam pressure and exposure time, manufacturers can deliberately modulate which compounds become extractable and in what quantities, all within processing windows measured in seconds rather than minutes. The fact that catechin remained dominant across all treatments indicates that DIC primarily shifts availability and relative distribution rather than eliminating key constituents. As demand grows for nutrient-dense, plant-based ingredients with verified bioactive content, the image of amaranth grains exploding into porous, antioxidant-rich flour inside a steel reactor may become a familiar sight, bridging five centuries of agricultural heritage with some of the most sophisticated food engineering available today.

Subject of Research: Effect of Instant Controlled Pressure Drop processing on phenolic compounds and fatty acids in amaranth grain

Article Title: Instant Controlled Pressure Drop Processing Modulates Phenolic Composition and Fatty Acid Profile in Amaranthus hypochondriacus Grain.

Article References: Rodríguez-Castillo, P., Teresa-Martínez, G., Alonzo-Macías, M., Téllez-Pérez, C., & Cardador-Martínez, A. (2026). Instant Controlled Pressure Drop Processing Modulates Phenolic Composition and Fatty Acid Profile in Amaranthus hypochondriacus Grain.. Current Research in Food Science, Article 101576. https://doi.org/10.1016/j.crfs.2026.101576

Image Credits: AI Generated

DOI: 10.1016/j.crfs.2026.101576

Keywords: amaranth, Instant Controlled Pressure Drop, phenolic compounds, fatty acids, squalene, catechin, functional foods, HPLC, GC-MS, pseudocereal, antioxidants, food processing